Ron Hunt
Director/Miembro de la Junta en Rallybio LLC .
Origen de la red de primer grado Ron Hunt.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Rallybio Holdings LLC
 Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Rallybio Holdings LLC engages in the provision of healthcare services. The company is headquartered in New Haven, CT.
5
| Subsidiary | Medical/Nursing Services | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ron Hunt a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| YUM! BRANDS, INC. | Restaurants | Corporate Officer/Principal | |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| CARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chairman Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
| Tufts University | College/University | Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| Harvard Medical School | College/University | Doctorate Degree | |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Cruz Blanca Initiative, Inc. | Founder | ||
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARVINAS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| 5AM Partners V LLC | Corporate Officer/Principal | ||
| VOR BIOPHARMA INC. | Biotechnology | Chief Executive Officer | |
| AKOUOS | Biotechnology | Director/Board Member | |
Grace Science Foundation
 Grace Science Foundation Miscellaneous Commercial ServicesCommercial Services Grace Science Foundation is a biotechnology company that was founded in 2017 by Matt Wilsey and Dr. Carolyn Bertozzi. The private company is based in San Francisco, CA. The company focuses on developing novel therapies based on the function of NGLY1, a key enzyme involved in proteostasis. Grace Science Foundation's deep knowledge of the NGLY1 pathway enables them to identify new ways of treating NGLY1 deficiency as well as more common diseases. | Miscellaneous Commercial Services | Consultant / Advisor | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
| ENTRADA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| 5AM Opportunities I GP LLC | Corporate Officer/Principal | ||
Plexium, Inc.
 Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Field Trip Psychedelics, Inc.
 Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Director/Board Member | |
| 501 ACQU | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Founder Chairman | |
Immuneel Therapeutics Pvt Ltd.
 Immuneel Therapeutics Pvt Ltd. Hospital/Nursing ManagementHealth Services Immuneel Therapeutics Pvt Ltd. operates as a cancer treatment center. The company was founded by Kiran Mazumdar-Shaw, Kush M. Parmar and Siddhartha Mukherjee is headquartered in Bengaluru, India. | Hospital/Nursing Management | Founder | |
| 5am Partners Vi LLC | Corporate Officer/Principal | ||
Evommune, Inc.
 Evommune, Inc. Miscellaneous Commercial ServicesCommercial Services Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member Founder Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
| Estuary Ventures LLC | Chief Executive Officer | ||
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Precede Biosciences, Inc.
 Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Miscellaneous Commercial Services | Director/Board Member | |
Novira Therapeutics LLC
 Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 44 |
| India | 3 |
| Canadá | 3 |
| Países Bajos | 2 |
| Suiza | 2 |
Sectorial
| Health Technology | 29 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Finance | 4 |
| Health Services | 3 |
Operativa
| Director/Board Member | 79 |
| Independent Dir/Board Member | 34 |
| Corporate Officer/Principal | 28 |
| Chief Executive Officer | 17 |
| Chairman | 11 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Kush Parmar | 32 |
| Timothy Shannon | 28 |
| Martin MacKay | 28 |
| Helen Boudreau | 22 |
| Robert Hopfner | 20 |
| Paula Soteropoulos | 13 |
| Stephen Uden | 5 |
| Ketan Patel | 1 |
- Bolsa de valores
- Insiders
- Ron Hunt
- Conexiones Empresas
